- Sep 30, 2005
- 96,212
- 15,787
- 126
Canadian court throws Viagra patent out. Generics might come soon, flood of American baby boomers to follow :biggrin:
http://www.cbc.ca/m/touch/canada/story/2012/11/08/supreme-court-viagra-pfizer.html
Viagra patent tossed out by Supreme Court Decision allows generic versions of drug to be produced CBC News
Canada's top court has ruled that Pfizer's patent on the company's groundbreaking erectile dysfunction drug Viagra is void.
The Supreme Court of Canada sided Thursday with Teva Canada Ltd., a division of the Israeli-based Teva pharmaceutical empire, in a longstanding court battle against Pfizer.
Teva had argued that the details provided in Pfizer's original patent application (number 2,163,446, granted in 1998 and set to expire in 2014) were insufficient in the first place.
Lower courts had sided with Pfizer in the dispute until Canada's top court agreed, in a 7-0 decision, with Teva's argument.
Pfizer's patent on Viagra "does not meet the disclosure requirements set out in the Act" Justice Lebel wrote in the ruling." I would therefore allow the appeal with costs and hold that Patent 2,163,446 is void."
The unanimous decision opens the door for Teva to introduce a generic version of Viagra in the near future. Other competing products such as tadalafil (known as Cialis) and vardenafil (Levitra) already exist.
http://www.cbc.ca/m/touch/canada/story/2012/11/08/supreme-court-viagra-pfizer.html
Viagra patent tossed out by Supreme Court Decision allows generic versions of drug to be produced CBC News
Canada's top court has ruled that Pfizer's patent on the company's groundbreaking erectile dysfunction drug Viagra is void.
The Supreme Court of Canada sided Thursday with Teva Canada Ltd., a division of the Israeli-based Teva pharmaceutical empire, in a longstanding court battle against Pfizer.
Teva had argued that the details provided in Pfizer's original patent application (number 2,163,446, granted in 1998 and set to expire in 2014) were insufficient in the first place.
Lower courts had sided with Pfizer in the dispute until Canada's top court agreed, in a 7-0 decision, with Teva's argument.
Pfizer's patent on Viagra "does not meet the disclosure requirements set out in the Act" Justice Lebel wrote in the ruling." I would therefore allow the appeal with costs and hold that Patent 2,163,446 is void."
The unanimous decision opens the door for Teva to introduce a generic version of Viagra in the near future. Other competing products such as tadalafil (known as Cialis) and vardenafil (Levitra) already exist.